期刊文献+

融合蛋白IFNα2a-α-MSH对小鼠黑色素瘤生长的抑制作用

Inhibitory Effect of Fusion Protein IFNα2a-α-MSH on Growth of Melanoma in Mice
原文传递
导出
摘要 目的观察融合蛋白IFNα2a-α-MSH对小鼠移植黑色素瘤生长的抑制作用。方法将小鼠黑色素瘤细胞株B16接种于C57BL/6小鼠背部皮下,待肿瘤直径长至4mm以上时,将小鼠分为4组,分别经肌肉注射生理盐水(阴性对照)、IFNα2a(9×106U/kg鼠重)、IFNα2a-α-MSH(9×106U/kg鼠重)及腹腔注射环磷酰胺(20mg/kg鼠重,阳性对照),前3组1次/d,阳性对照组隔日1次,共11d。隔日测量肿瘤大小;末次给药后24h,处死小鼠,称瘤重,并计算肿瘤抑制率。结果 IFNα2a-α-MSH可明显抑制小鼠黑色素瘤的生长,且其抑瘤作用明显强于IFNα2a。结论 IFNα2a-α-MSH对小鼠黑色素瘤生长有较强的抑制作用,为IFNα2a-α-MSH临床治疗黑色素瘤提供了实验依据。 Objective To observe the inhibitory effect of fusion protein IFNα2a-α-MSH(α-melanocyte-stimulating hormone) on the growth of transplanted melanoma in mice.Methods Melanoma cell strain B16 was inoculated s.c.to C57BL /6 mice.After the diameters of tumors were more than 4 mm,the mice were divided into four groups.The mice in group 1~3 were injected i.m.with physiological saline(negative control),IFNα2a(9 × 106 U /kg body weight)and IFNα2a-α-MSH(9 × 106 U /kg body weight)respectively,once a day for 11 d,while those in group 4 were injected i.p.with cyclophosphamid(20 mg /kg body weight,positive control) every other day for 11 d.The sizes of tumors were measured every other day.The mice were killed 24 h after the last injection,and their tumors were weighed,based on which the inhibitory rate to growth of tumors was calculated.Results IFNα2a-α-MSH inhibited the growth of melanoma in mice significantly,and its inhibitory effect was significantly stronger than that of IFNα2a.Conclusion IFNα2a-α-MSH showed strong inhibitory effect on the growth of melanoma in mice,which provided an experimental basis for the clinical therapy of melanoma with IFNα2a-α-MSH.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第7期741-743,共3页 Chinese Journal of Biologicals
关键词 干扰素Α2A Α-黑素细胞刺激素 黑色素瘤 实验性 IFNα2a α-Melanocyte-stimulating hormone(α-MSH) Melanoma experimental
  • 相关文献

参考文献14

  • 1Brassard DL, Grance M J, Bordens RW. Interferon-alpha as an immunotherapeutic protein [J]. J Leukoc Biol, 2002, 71 (4):565-581.
  • 2孟洁如,颜真,赵宁,李波,张英起.导向性人干扰素α2a工程菌生物学特性的稳定性[J].中国生物制品学杂志,2003,16(4):222-224. 被引量:9
  • 3李蠡,邢新,薛春雨,张敬德.α-黑素细胞刺激素对恶性黑色素瘤细胞Fas/FasL表达的影响及其与凋亡的关系[J].临床肿瘤学杂志,2005,10(3):230-234. 被引量:2
  • 4Harem C, Verma S, Petrella T, et al. Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review[J].Cancer Treat Rev, 2008, 34 (2): 145-156.
  • 5王小霞,张英起,余春艳,薛晓畅,王增禄,吴守振.导向性IFN-α2a-α-MSH基因的克隆、表达、纯化及鉴定[J].第四军医大学学报,2007,28(12):1084-1087. 被引量:1
  • 6Dadachova E, Casadevall A. Renaissance of targeting molecules for melanoma [J]. Cancer Biother Radio Pharm, 2006, 21 (6): 545- 552.
  • 7吴振林,董坚.多肽分子在肿瘤基础和临床中的应用[J].昆明医学院学报,2006,27(5):115-119. 被引量:1
  • 8Zhu N, Lalla R, Eves P, et al. Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alphamelanocyte-stimulating hormone [J]. Br J Cancer, 2004, 90 (7): 1457-1463.
  • 9Eves P, Haycock J, Layton C, et al. Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cell [J].Br J Cancer, 2003, 89 (10): 2004-2015.
  • 10Froidevaux S, Calame-Christe M, Tanner H, et al. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis [J ]. J Nucl Med, 2002, 43 (12): 1699-1706.

二级参考文献30

  • 1孔天翰,林山,韩雪飞,琚济杭,董伟华.蝎毒多肽对肿瘤细胞的抑制作用研究[J].中国病理生理杂志,2004,20(6):968-972. 被引量:22
  • 2刘磊,孟洁如,赵宁,颜真,张英起.融合蛋白IFN-α2b-NGR在荷瘤小鼠体内的肿瘤局部分布及组织定位[J].第四军医大学学报,2004,25(15):1400-1402. 被引量:1
  • 3李蠡,邢新,薛春雨,张敬德.α-黑素细胞刺激素对恶性黑色素瘤细胞Fas/FasL表达的影响及其与凋亡的关系[J].临床肿瘤学杂志,2005,10(3):230-234. 被引量:2
  • 4杜平.医用干扰素[M].北京:解放军出版社,1984.231-235.
  • 5Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22(20): 3138 - 51.
  • 6Zhu N, Lalla R, Eves P, et al. Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone. Br J Cancer 2004;90(7): 1457 -63.
  • 7Eves P, Haycock J, Layton C. Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br J Cancer 2003; 89(10): 2004 - 15.
  • 8Hedley SJ, Gawkrodger DJ, Weetman AP, et al. alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol 1998; 138(3): 536 -43.
  • 9Slominski A, Wortsman J, Carlson A J, et al. Malignant melanoma. Arch Pathol Lab Med 2001; 125 (10): 1295 - 306.
  • 10Haycock JW, Rowe S J, Cartledge S, et al. Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem 2000; 275(21): 15629 -36.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部